Product image of Halixol (Ambroxol Hydrochloride) supplied by GNH India

Halixol

Active Ingredient:
Ambroxol Hydrochloride
Origin:
EU

Halixol (Ambroxol Hydrochloride)

Halixol is an oral medication that contains the active ingredient ambroxol hydrochloride. It is marketed in the European Union as a mucolytic agent used to facilitate the clearance of respiratory mucus. The product is formulated for systemic absorption and is intended for patients who need assistance in thinning and loosening thick bronchial secretions. Halixol belongs to the drug class of mucolytics and is classified under ATC code R05CB01.

Manufacturer / TM Owner

Egis Pharmaceuticals Plc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Halixol is indicated for the symptomatic relief of cough and mucus accumulation in a variety of respiratory conditions. It is commonly prescribed when thick or excessive secretions impair airway clearance, helping patients breathe more comfortably.

  • Cough associated with excessive or thick mucus
  • Acute bronchitis with productive cough
  • Chronic bronchitis to improve sputum expectoration
  • Chronic obstructive pulmonary disease (COPD) to aid mucociliary clearance
  • Asthma when mucus plugging contributes to symptoms

Side Effects

The safety profile of Halixol includes both frequently observed and less common reactions that may require medical attention.

Common

  • Nausea or mild stomach discomfort
  • Diarrhea or loose stools
  • Taste alteration or mild metallic taste
  • Skin rash or mild itching

Serious

  • Severe allergic reaction such as anaphylaxis
  • Persistent vomiting or signs of gastrointestinal bleeding

Precautions & Warnings

Before using Halixol, certain health considerations should be reviewed to ensure safe and effective treatment.

  • Use with caution in patients with known hypersensitivity to ambroxol
  • Assess liver or kidney impairment, as metabolism may be altered
  • Monitor elderly patients closely due to potential increased sensitivity
  • Discuss use during pregnancy or breastfeeding with a healthcare professional
  • Avoid use in children under the age recommended by local guidelines
  • Consider potential interactions with other mucolytic or expectorant agents

Avoid Interactions

Halixol may affect the activity of other medicines, and certain combinations should be avoided or used under supervision.

Avoid

  • Concomitant use with strong CYP3A4 inhibitors, which could increase ambroxol levels
  • Combination with other mucolytic agents that may cause excessive thinning of mucus

Use with caution

  • Anticoagulants, as ambroxol may influence bleeding risk
  • Bronchodilators, to monitor for additive respiratory effects
  • Antibiotics that are metabolized by the same hepatic pathways

Frequently Asked Questions

Ambroxol increases surfactant production and stimulates mucociliary clearance, which reduces the viscosity of mucus and helps it be expelled from the airways.

Yes, Halixol is commonly prescribed for acute bronchitis when a productive cough with thick mucus is present, to aid mucus clearance.

Use in children should follow local pediatric guidelines; it is generally not recommended for very young children without medical supervision.

Common side effects include nausea, mild stomach discomfort, diarrhea, a metallic taste, and occasional mild skin rash or itching.

Avoid combining Halixol with strong CYP3A4 inhibitors and with other mucolytic agents unless directed by a healthcare professional.

Pregnancy safety has not been fully established; discuss potential risks and benefits with a healthcare provider before use.

In COPD, Halixol can improve mucociliary clearance, making it easier to expectorate thick secretions and potentially reducing cough frequency.

Serious allergic reactions such as anaphylaxis are rare but possible; seek immediate medical attention if symptoms like swelling, rash, or difficulty breathing occur.

Patients with significant liver impairment should be evaluated by a clinician, as metabolism of ambroxol may be affected.

Ambroxol may influence bleeding risk; use with anticoagulants under medical supervision and monitor for signs of abnormal bleeding.

If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose; do not double the dose.

The regulatory status varies by country; in some EU markets it may be prescription‑only, while in others it could be available without a prescription.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ambroxol Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT